ASCL1 and small cell lung carcinoma: The mechanism by which LSD1 inhibitors block NE differentiation in SCLC has also been linked to increased expression of the mRNA binding protein ZFP36L1, which in turn also contributes to ASCL1 suppression (Fig. 5) (117).